Financial Performance - The company's revenue for Q3 2022 was ¥4,287,062,608.64, a decrease of 29.26% compared to ¥6,059,928,874.39 in the same period last year[7]. - Net profit attributable to shareholders was ¥179,738,947.16, down 23.49% from ¥234,913,119.48 year-on-year[7]. - Basic earnings per share decreased to ¥0.0970, down 23.68% from ¥0.1271 in the same period last year[7]. - Total operating revenue for the current period is ¥14,896,319,948.47, a decrease of 17.5% compared to ¥18,086,356,343.33 in the previous period[26]. - Net profit for the current period is ¥1,274,260,552.53, slightly up from ¥1,253,096,605.47 in the previous period[26]. - The net profit for the current period is approximately ¥987.26 million, an increase from ¥940.08 million in the previous period, representing a growth of about 5%[28]. - The total comprehensive income for the current period is approximately ¥1,024.57 million, compared to ¥906.83 million in the previous period, indicating an increase of around 13%[28]. - The basic earnings per share for the current period is ¥0.5195, up from ¥0.5055 in the previous period, reflecting a growth of about 2.0%[28]. Cash Flow and Assets - The net cash flow from operating activities was ¥1,640,249,107.89, a significant decline of 68.74% compared to ¥5,246,962,076.13 in the previous year[12]. - Cash flow from operating activities for the current period is approximately ¥1,640.25 million, a decrease from ¥5,246.96 million in the previous period[32]. - Cash and cash equivalents at the end of the period amount to approximately ¥1,386.76 million, compared to ¥1,283.58 million at the end of the previous period, showing an increase of about 8%[32]. - The company's cash and cash equivalents were reported at 1,388,936,499.07 CNY, up from 1,115,957,159.62 CNY at the start of the year, indicating a growth of approximately 24.5%[19]. - The total assets at the end of the reporting period were ¥18,062,119,861.99, reflecting a slight increase of 0.12% compared to the previous year[7]. - Total assets increased to ¥18,078,897,719.28 from ¥18,058,126,434.00, reflecting a growth of 0.11%[25]. - The company's fixed assets increased to 8,429,500,327.18 CNY from 7,781,661,600.53 CNY, indicating a growth of about 8.3%[19]. Liabilities and Equity - Total liabilities decreased to ¥5,734,181,449.10 from ¥6,303,484,786.33, a reduction of 9%[25]. - The total equity attributable to shareholders was ¥11,397,350,949.32, an increase of 4.98% compared to the previous year[7]. - The total equity attributable to shareholders of the parent company rose to ¥11,960,731,504.18, an increase of 5% from ¥11,393,240,662.95[25]. Operating Costs and Expenses - The company’s gross profit margin decreased, with operating costs at ¥13,077,858,593.39, down 17.90% from ¥15,929,579,111.08[12]. - Total operating costs for the current period are ¥13,781,857,723.36, down 18.4% from ¥16,844,208,399.69 in the previous period[26]. - The company reported a decrease in R&D expenses to ¥97,035,272.22, down 25.96% from ¥131,058,912.06 year-on-year[12]. - Research and development expenses decreased to ¥97,035,272.22, a reduction of 26% from ¥131,058,912.06 in the previous period[26]. - The company reported a tax expense of approximately ¥296.11 million, down from ¥318.64 million in the previous period, reflecting a decrease of about 7%[28]. Shareholder Information - The total number of common shareholders at the end of the reporting period was 129,731, with COFCO Bio-chemical Investment Co., Ltd. holding 47.35% of shares, amounting to 883,233,262 shares[15]. - The total number of preferred shareholders and their holdings were not applicable for this reporting period[18]. - The report indicates that there are no known related party relationships among the top ten shareholders, ensuring independent governance[15]. Government Support and Other Income - The company received government subsidies amounting to ¥446,839,537.42 year-to-date, which is a significant contribution to other income[11]. - The company’s financial expenses decreased significantly by 106.46% to -¥8,053,157.05 due to reduced loan interest and increased exchange gains[12]. Market Strategy - The company is focused on expanding its market presence and developing new products and technologies, although specific details were not disclosed in the report[17]. - The company has not reported any significant mergers or acquisitions during this period[17].
中粮科技(000930) - 2022 Q3 - 季度财报